Fred Kyeyune

发表

Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage

E. Arts, Richard Gibson, G. Nickel, 2015, AIDS Research and Therapy.

First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda

E. Arts, A. Poon, Richard Gibson, 2019, AIDS Research and Therapy.

Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure

E. Arts, Richard Gibson, M. Quiñones-Mateu, 2016, Antimicrobial Agents and Chemotherapy.

Detection of novel HIV-1 drug resistance mutations by support vector analysis of deep sequence data and experimental validation

D. Lizotte, E. Arts, A. Poon, 2019, bioRxiv.

Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.

E. Arts, A. Poon, Richard Gibson, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters

M. Wainberg, B. Brenner, J. Routy, 2017, The Journal of antimicrobial chemotherapy.

Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection

C. Morrison, Pai-Lien Chen, C. Kwok, 2018, PLoS pathogens.

High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.

C. Petropoulos, E. Paxinos, E. Arts, 2004, AIDS research and human retroviruses.

A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.

Matthew S. Lalonde, E. Arts, F. Bajunirwe, 2008, AIDS research and human retroviruses.

Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda

C. Kato, I. Nankya, Fred Kyeyune, 2020, AIDS Research and Therapy.

Genotypic antiretroviral drug resistance in a cohort of HIV infected drug naïve Ugandan Women

Fred Kyeyune, 2010 .

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa

C. Morrison, Pai-Lien Chen, C. Kwok, 2016, EBioMedicine.

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries

E. Arts, A. Poon, Michael Crawford, 2017, Infectious Diseases of Poverty.

Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period

E. Arts, C. Kityo, B. Rodriguez, 2013, AIDS.

High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.

E. Arts, M. Quiñones-Mateu, C. Kityo, 2021, The Journal of antimicrobial chemotherapy.

Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda

J. Karn, W. Boom, D. Winner, 2022, Retrovirology.

Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in Uganda.

E. Arts, A. Poon, Richard Gibson, 2018, AIDS research and human retroviruses.